Skip to main content

ACAM2000

Pronunciation: A-cam two-thou-zand
Generic name: smallpox and mpox (Vaccinia) vaccine, live
Dosage form: injection, powder, lyophilized, for solution (multidose)
Drug class: Viral vaccines

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 3, 2024.

What is the ACAM2000 smallpox/mpox vaccine?

ACAM2000 is a prescription vaccine that may be used to prevent smallpox and mpox disease in people of any age with a high chance of getting smallpox or mpox (previously called monkey pox).

ACAM2000 gained an extension of its FDA approval to include mpox on August 29, 2024. ACAM2000 was first approved for smallpox on September 4, 2007.

ACAM2000 side effects

The most common side effects of ACAM2000 are:

These side effects are less likely to occur in people who have already been vaccinated with a smallpox/mpox vaccine compared to those who have never been vaccinated with this type of vaccine before.

Serious side effects and warnings

ACAM2000 carries a Boxed Warning for myocarditis and pericarditis.

The risk of experiencing serious vaccination complications must be weighed against the risks of
experiencing a potentially severe or fatal smallpox or Mpox infection. 

Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart) have occurred with ACAM2000. Most cases have occurred within 1-2 weeks after vaccination. Symptoms of myocarditis and pericarditis include:

Symptoms of myocarditis and pericarditis may be different in children and may also include:

ACAM2000 contains live vaccinia virus (a “pox”-type virus) that can be spread to individuals who have close contact with the vaccinated individual. ACAM2000 can cause serious complications in vaccinated individuals and in their close contacts to whom the vaccine virus has spread.

Inflammation of the brain or spinal cord has also occurred in people vaccinated with ACAM2000.

Serious skin infections can also occur with ACAM2000 such as a rash caused by widespread infection of the skin (known as eczema vaccinatum), a buildup of inflamed tissue around the vaccination site that may at first look like a bullseye and will grow into a large, non-healing sore (known as progressive vaccinia).

There is a possibility that the vaccine virus from ACAM2000 may spread through the blood to other parts of your body and cause further side effects.

Because the vaccine has a live virus, care must be taken to avoid spreading the virus from the vaccination site to other people or other parts of the body, which may occur by trauma, scratching, or incorrect disposal of the dressing that covers the vaccination site. If the virus is spread to a person who should not get the vaccine, the side effects can be very serious and life-threatening. The result of accidental infection is a pock lesion or lesions at an unwanted site in the person being vaccinated or their close contact and resembles the vaccination site. Selfinoculation occurs most often on the face, eyelid, nose, anus, and mouth, but lesions at any site of traumatic inoculation can occur. Accidental infection of the eye (which may cause swelling of the cornea causing watery painful eyes and blurred vision, scarring of the cornea, and blindness).

There is a risk of the unborn baby dying if pregnant females are vaccinated with ACAM2000.

Severe allergic reactions after vaccination with ACAM2000 are also possible. Tell your healthcare provider immediately if you experience any swelling of your face or throat, a skin rash, a fast heart rate, or difficulty breathing.

To report suspected side effects, contact Emergent BioSolutions at 1-877-246-8472 and medicalinformation@ebsi.com or VAERS at 800-822-7967 and https://vaers.hhs.gov.  

Who should not get ACAM2000?

Do not receive ACAM2000 if you have:

People who may have a weakened immune system include those who:

If you are unable to receive ACAM2000 because of a problem with your immune system, talk to your healthcare provider about other options to protect against smallpox and mpox.

Before receiving ACAM2000

Before receiving ACAM2000, tell your healthcare provider about all your medical conditions, because some may increase your risk of having side effects from the vaccine. Tell them if you:

Tell your healthcare provider if any of the above apply to you or to anyone with whom you live, work, or have close contact.

How is ACAM2000 given?

ACAM2000 is given "percutaneously". This means your healthcare provider will make 15 pokes in the skin of your upper arm with a needle containing a small drop of ACAM2000.

If you need medical care in the month after your vaccination, tell your healthcare provider you just got a smallpox vaccination.

Certain people, such as laboratory workers who work with smallpox, are at risk of being exposed to smallpox over a long period.

What to expect at your vaccination site after receiving ACAM2000.

If you have never been vaccinated with a smallpox/mpox vaccine before, the vaccination site will develop a small red, itchy bump in 2 to 5 days that will become a blister and fill with pus over the next few days.

If you have been vaccinated with a smallpox/mpox vaccine before, you may have a reduced response to ACAM2000.

How do I care for my ACAM2000 vaccination site?

Your vaccination site is considered “infectious” from the time you get vaccinated until a scab forms and falls off and the skin at the vaccination site is fully healed. It is important to care for the vaccination site properly so that the virus doesn’t spread to other parts of your body or to others. 

It is important to ALWAYS:

What should I avoid after having my ACAM2000 vaccination?

Do not use creams or ointments on the vaccination site.

Do not scratch or pick at the vaccination site.

Do not touch or scrub the vaccination site while taking a bath or shower.

Do not use a bandage that blocks air from the vaccination site. This could cause the skin at
the vaccination site to soften and wear away.

For 6 weeks after ACAM2000 vaccination and until the vaccination site has healed, avoid:

ACAM2000 may cause some tests for Tuberculosis (TB) or Syphilis to give the wrong result. If you need to be tested for TB or Syphilis within 6 weeks of receiving ACAM2000, tell your healthcare provider that you received ACAM2000.  

It is not known if the vaccine virus can be spread to cats, dogs, or other household pets, or whether pets can spread the virus to other people in the household.

ACAM2000 ingredients

ACAM2000 active ingredients: live vaccinia virus grown in African Green Monkey kidney (Vero) cells.

Inactive ingredients: HEPES buffer, human serum albumin, sodium chloride, mannitol, trace amounts of the antibiotics neomycin and polymyxin B, Glycerin, and Phenol.

Who makes ACAM2000?

Emergent Product Development Gaithersburg Inc. makes ACAM2000.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Discover a treatment option for Type II Diabetes